Posts by: Tim J. Smith, PhD

Boston Scientific Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before…

More

Cadence Pricing Spineometer: 1 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Cadence Design Systems, a global software and technology company supporting the silicon chip and pharmaceutical design industries among others, had a negative…

More

Emerson Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Emerson, a global electrical products and engineering services concern, had a strongly positive Q2 2024. Revenue rose 17 % to $4.4 billion…

More

Hilton Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Hilton, a global hotel, resort, and timeshare concern, had a strongly positive Q1 2024. Revenue rose 12% % to $2.6 billion and…

More

Adobe Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD July 26, 2024

Adobe, a visual creativity software-as-a-service company, had a positive Q2 2024. Revenue rose 10 % to $5.3 billion and earnings before interest…

More

D.R. Horton Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD July 26, 2024

D.R. Horton, a residential housing developer, had a positive Q3 2024. Revenue rose 5.8% to $9.2 billion and earnings before interest and…

More

J.B. Hunt Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD July 26, 2024

J.B. Hunt, a trucking and logistics company, had a negative Q2 2024. Revenue fell 6.5 % to $2.9 billion and earnings before…

More

Netflix Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD July 26, 2024

Netflix, a video-on-demand subscription service, had a highly positive Q2 2024. Revenue rose 17 % to $9.6 billion and earnings before interest…

More

Boeing Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD June 28, 2024

Boeing, global aerospace manufacturer, had a challenging Q1 2024. Revenue fell 7.5% to $16.6 billion but earnings before interest and taxes rose…

More

Gilead Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD June 28, 2024

Gilead, a biopharmaceutical company, had mixed Q1 2024. Revenue rose 5.3% to $6.7 billion but earnings before interest and taxes fell 350%…

More

About The Author

timjsmith
Tim J. Smith, PhD, is the founder and CEO of Wiglaf Pricing, an Adjunct Professor of Marketing and Economics at DePaul University, and the author of Pricing Done Right (Wiley 2016) and Pricing Strategy (Cengage 2012). At Wiglaf Pricing, Tim leads client engagements. Smith’s popular business book, Pricing Done Right: The Pricing Framework Proven Successful by the World’s Most Profitable Companies, was noted by Dennis Stone, CEO of Overhead Door Corp, as "Essential reading… While many books cover the concepts of pricing, Pricing Done Right goes the additional step of applying the concepts in the real world." Tim’s textbook, Pricing Strategy: Setting Price Levels, Managing Price Discounts, & Establishing Price Structures, has been described by independent reviewers as “the most comprehensive pricing strategy book” on the market. As well as serving as the Academic Advisor to the Professional Pricing Society’s Certified Pricing Professional program, Tim is a member of the American Marketing Association and American Physical Society. He holds a BS in Physics and Chemistry from Southern Methodist University, a BA in Mathematics from Southern Methodist University, a PhD in Physical Chemistry from the University of Chicago, and an MBA with high honors in Strategy and Marketing from the University of Chicago GSB.